As filed with the Securities and Exchange Commission on November 7, 2024
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
SYNAPTICS INCORPORATED
(Exact name of registrant as specified in its charter)
| Delaware | 77-0118518 | |||||||
(State or other jurisdiction of incorporation or organization) | (IRS Employer Identification No.) | |||||||
1109 McKay Drive
San Jose, California 95131
(Address of Principal Executive Offices) (Zip Code)
AMENDED AND RESTATED 2019 EQUITY AND INCENTIVE
COMPENSATION PLAN
(Full title of the plan)
Ken Rizvi
Senior Vice President and Chief Financial Officer
1109 McKay Drive
San Jose, California 95131
(Name and address of agent for service)
(408) 904-1100
(Telephone number, including area code, of agent for service)
Copies to:
Lisa Bodensteiner Senior Vice President, Chief Legal Officer and Secretary Synaptics Incorporated 1109 McKay Drive San Jose, California 95131 Tel: (408) 904-1100 Fax: (408) 904-1110 | Micheal J. Reagan, Esq. W. Stuart Ogg, Esq. Goodwin Procter LLP 601 Marshall Street Redwood City, CA 94063 Tel: (650) 739-3939 Fax: (650) 739-3900 | |||||||
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☒ | Accelerated filer | ☐ | |||||||||||||||||
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ | |||||||||||||||||
| Emerging growth company | ☐ | |||||||||||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
EXPLANATORY NOTE
Synaptics Incorporated, a Delaware corporation (the “Registrant”) is filing this Registration Statement to register an additional 1,400,000 shares of its common stock, par value $0.001 per share (“Common Stock”), for issuance under the Registrant’s Amended and Restated 2019 Equity and Incentive Compensation Plan (the “2019 Plan”). The 2019 Plan was amended by the Registrant’s Board of Directors on July 30, 2024 to increase the number of shares of Common Stock authorized for issuance thereunder by 1,400,000 shares, and such amendment was approved by the Registrant’s stockholders on October 29, 2024.
This Registration Statement is being filed for the purpose of increasing the number of securities of the same class as other securities for which a Registration Statement on Form S-8 relating to the same benefit plan is effective pursuant to the amendment to the 2019 Plan described above and the issuance of the substitute restricted stock unit awards. The Registrant previously registered shares of its Common Stock for issuance under the 2019 Plan under a Registration Statement on Form S-8 filed with the Securities and Exchange Commission (“SEC”) on November 1, 2019 (File No. 333-234437), November 2, 2020 (File No. 333-249793), December 2, 2021 (File No. 333-261460), November 3, 2022 (File No. 333-268145) and November 9, 2023 (File No. 333-275459). Pursuant to General Instruction E to Form S-8, this Registration Statement hereby incorporates by reference the contents of the Registration Statements referenced above with respect to the shares of Common Stock registered under the 2019 Plan, except to the extent supplemented or amended or superseded by the information set forth or incorporated herein.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
| Item 8. | Exhibits. | ||||
| Exhibit No. | Description | |||||||
| 5.1 | ||||||||
| 10.1 | ||||||||
| 23.1 | ||||||||
| 23.2 | ||||||||
| 24.1 | Power of Attorney (included on the signature page) | |||||||
| 107 | Filing fee table* | |||||||
| * | Filed herewith. | ||||
| (1) | Incorporated by reference to Exhibit 10.1 of our Current Report on Form 8-K filed with the SEC on October 31, 2024. | ||||
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of San Jose, State of California, on November 7, 2024.
| SYNAPTICS INCORPORATED | ||||||||
| By: | /s/ Michael E. Hurlston | |||||||
| Michael E. Hurlston | ||||||||
| President and Chief Executive Officer | ||||||||
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Michael Hurlston and Ken Rizvi and each or either of them, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this registration statement on Form S-8, including any and all post-effective amendments and amendments thereto, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or their or his or her substitutes or substitute, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement on Form S-8 has been signed below by the following persons on behalf of Synaptics Incorporated and in the capacities and on the dates indicated:
| Title | Date | ||||||||||||||||
| /s/ Michael E. Hurlston | President, Chief Executive Officer and | November 7, 2024 | |||||||||||||||
| Michael E. Hurlston | Director (Principal Executive Officer) | ||||||||||||||||
| /s/ Ken Rizvi | Chief Financial Officer (Principal Financial | November 7, 2024 | |||||||||||||||
| Ken Rizvi | Officer) | ||||||||||||||||
| /s/ Esther Song | Vice President and Corporate | November 7, 2024 | |||||||||||||||
| Esther Song | Controller (Principal Accounting Officer) | ||||||||||||||||
| /s/ Nelson C. Chan | Chairman of the Board and Director | November 7, 2024 | |||||||||||||||
| Nelson C. Chan | |||||||||||||||||
| /s/ Jeffrey D. Buchanan | Director | November 7, 2024 | |||||||||||||||
| Jeffrey D. Buchanan | |||||||||||||||||
| /s/ Keith B. Geeslin | Director | November 7, 2024 | |||||||||||||||
| Keith B. Geeslin | |||||||||||||||||
| /s/ Susan J. Hardman | Director | November 7, 2024 | |||||||||||||||
| Susan J. Hardman | |||||||||||||||||
| /s/ Patricia Kummrow | Director | November 7, 2024 | |||||||||||||||
| Patricia Kummrow | |||||||||||||||||
| /s/ Vivie Lee | Director | November 7, 2024 | |||||||||||||||
| Vivie Lee | |||||||||||||||||
| /s/ James L. Whims | Director | November 7, 2024 | |||||||||||||||
| James L. Whims | |||||||||||||||||